JournalConnective Tissue Research
PublisherTaylor and Francis Inc.
MetadataShow full item record
AbstractPurpose: Optogenetics is an emerging alternative to traditional electrical stimulation to initiate action potentials in activatable cells both ex vivo and in vivo. Optogenetics has been commonly used in mammalian neurons and more recently, it has been adapted for activation of cardiomyocytes and skeletal muscle. Therefore, the aim of this study was to evaluate the stimulation feasibility and sustain isometric muscle contraction and limit decay for an extended period of time (1s), using non-invasive transdermal light activation of skeletal muscle (triceps surae) in vivo. Materials and Methods: We used inducible Cre recombination to target expression of Channelrhodopsin-2 (ChR2(H134R)-EYFP) in skeletal muscle (Acta1-Cre) in mice. Fluorescent imaging confirmed that ChR2 expression is localized in skeletal muscle and does not have specific expression in sciatic nerve branch, therefore, allowing for non-nerve mediated optical stimulation of skeletal muscle. We induced muscle contraction using transdermal exposure to blue light and selected 10 Hz stimulation after controlled optimization experiments to sustain prolonged muscle contraction. Results: Increasing the stimulation frequency from 10 Hz to 40 Hz increased the muscle contraction decay during prolonged 1s stimulation, highlighting frequency dependency and importance of membrane repolarization for effective light activation. Finally, we showed that optimized pulsed optogenetic stimulation of 10 Hz resulted in comparable ankle torque and contractile functionality to that of electrical stimulation. Conclusions: Our results demonstrate the feasibility and repeatability of non-invasive optogenetic stimulation of muscle in vivo and highlight optogenetic stimulation as a powerful tool for non-invasive in vivo direct activation of skeletal muscle.
SponsorsEunice Kennedy Shriver National Institute of Child Health and Human Development (R03 HD094594 to MLK) and The National Institute of Neurological Disorders and Stroke (R01 NS069777 to CSC).
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/14236
- Optogenetic control of contractile function in skeletal muscle.
- Authors: Bruegmann T, van Bremen T, Vogt CC, Send T, Fleischmann BK, Sasse P
- Issue date: 2015 Jun 2
- Optogenetic analysis of neuromuscular transmission in the colon of ChAT-ChR2-YFP BAC transgenic mice.
- Authors: Perez-Medina AL, Galligan JJ
- Issue date: 2019 Nov 1
- Direct optogenetic stimulation of smooth muscle cells to control gastric contractility.
- Authors: Vogt M, Schulz B, Wagdi A, Lebert J, van Belle GJ, Christoph J, Bruegmann T, Patejdl R
- Issue date: 2021
- Optogenetic Modulation of Urinary Bladder Contraction for Lower Urinary Tract Dysfunction.
- Authors: Park JH, Hong JK, Jang JY, An J, Lee KS, Kang TM, Shin HJ, Suh JF
- Issue date: 2017 Jan 18
- Spot light on skeletal muscles: optogenetic stimulation to understand and restore skeletal muscle function.
- Authors: van Bremen T, Send T, Sasse P, Bruegmann T
- Issue date: 2017 Aug